Avadel Pharmaceuticals Plc Stock Price History
| AVDL Stock | USD 8.61 0.38 4.23% |
Below is the normalized historical share price chart for Avadel Pharmaceuticals PLC extending back to June 07, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avadel Pharmaceuticals stands at 8.61, as last reported on the 16th of February 2025, with the highest price reaching 9.08 and the lowest price hitting 8.60 during the day.
If you're considering investing in Avadel Stock, it is important to understand the factors that can impact its price. Avadel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0484, which signifies that the company had a -0.0484 % return per unit of standard deviation over the last 3 months. Avadel Pharmaceuticals PLC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avadel Pharmaceuticals' risk adjusted performance of (0.09), and Mean Deviation of 3.15 to double-check the risk estimate we provide.
At this time, Avadel Pharmaceuticals' Issuance Of Capital Stock is quite stable compared to the past year. Stock Based Compensation To Revenue is expected to rise to 0.53 this year, although the value of Common Stock Total Equity will most likely fall to about 501 K. . At this time, Avadel Pharmaceuticals' Price Fair Value is quite stable compared to the past year. Avadel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of June 1996 | 200 Day MA 15.2769 | 50 Day MA 13.672 | Beta 1.632 |
Avadel |
Sharpe Ratio = -0.0484
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVDL |
Estimated Market Risk
| 4.81 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avadel Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avadel Pharmaceuticals by adding Avadel Pharmaceuticals to a well-diversified portfolio.
Price Book 11.1122 | Enterprise Value Ebitda (6.43) | Price Sales 6.0052 | Shares Float 83.2 M | Wall Street Target Price 24.7 |
Avadel Pharmaceuticals Stock Price History Chart
There are several ways to analyze Avadel Stock price data. The simplest method is using a basic Avadel candlestick price chart, which shows Avadel Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 21, 2024 | 11.66 |
| Lowest Price | January 27, 2025 | 7.49 |
Avadel Pharmaceuticals February 16, 2025 Stock Price Synopsis
Various analyses of Avadel Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Avadel Stock. It can be used to describe the percentage change in the price of Avadel Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Avadel Stock.| Avadel Pharmaceuticals Price Daily Balance Of Power | (0.79) | |
| Avadel Pharmaceuticals Price Action Indicator | (0.42) | |
| Avadel Pharmaceuticals Price Rate Of Daily Change | 0.96 |
Avadel Pharmaceuticals February 16, 2025 Stock Price Analysis
Avadel Stock Price History Data
The price series of Avadel Pharmaceuticals for the period between Mon, Nov 18, 2024 and Sun, Feb 16, 2025 has a statistical range of 8.81 with a coefficient of variation of 18.01. The prices are distributed with arithmetic mean of 9.93. The median price for the last 90 days is 10.23.| Open | High | Low | Close | Volume | ||
02/16/2025 | 8.99 | 9.08 | 8.60 | 8.61 | ||
| 02/14/2025 | 8.99 | 9.08 | 8.60 | 8.61 | 914,535 | |
| 02/13/2025 | 8.94 | 9.10 | 8.81 | 8.99 | 890,276 | |
| 02/12/2025 | 8.91 | 9.34 | 8.80 | 8.91 | 1,451,753 | |
| 02/11/2025 | 9.00 | 9.19 | 8.71 | 9.00 | 1,768,885 | |
| 02/10/2025 | 8.00 | 9.16 | 8.00 | 9.09 | 2,845,711 | |
| 02/07/2025 | 7.98 | 8.20 | 7.88 | 8.11 | 1,473,996 | |
| 02/06/2025 | 8.33 | 8.46 | 7.93 | 8.00 | 881,717 | |
| 02/05/2025 | 8.25 | 8.63 | 8.23 | 8.33 | 1,538,915 | |
| 02/04/2025 | 7.95 | 8.19 | 7.79 | 8.18 | 1,081,540 | |
| 02/03/2025 | 7.75 | 8.07 | 7.70 | 7.97 | 1,584,320 | |
| 01/31/2025 | 7.69 | 8.06 | 7.59 | 7.90 | 1,369,217 | |
| 01/30/2025 | 7.74 | 7.84 | 7.57 | 7.69 | 1,022,715 | |
| 01/29/2025 | 7.60 | 7.75 | 7.44 | 7.66 | 1,009,155 | |
| 01/28/2025 | 7.57 | 7.71 | 7.41 | 7.64 | 1,001,667 | |
| 01/27/2025 | 7.82 | 8.01 | 7.40 | 7.49 | 1,252,190 | |
| 01/24/2025 | 7.90 | 7.98 | 7.77 | 7.85 | 973,128 | |
| 01/23/2025 | 8.02 | 8.07 | 7.81 | 7.94 | 1,453,057 | |
| 01/22/2025 | 7.81 | 8.02 | 7.75 | 8.00 | 1,463,778 | |
| 01/21/2025 | 7.93 | 8.03 | 7.63 | 7.90 | 2,362,854 | |
| 01/17/2025 | 8.05 | 8.06 | 7.75 | 7.75 | 1,139,944 | |
| 01/16/2025 | 8.16 | 8.24 | 7.93 | 8.00 | 1,453,789 | |
| 01/15/2025 | 8.64 | 8.74 | 8.14 | 8.16 | 1,543,256 | |
| 01/14/2025 | 7.90 | 8.34 | 7.78 | 8.05 | 1,876,575 | |
| 01/13/2025 | 7.92 | 8.35 | 7.61 | 7.82 | 3,001,961 | |
| 01/10/2025 | 8.06 | 8.24 | 7.39 | 7.90 | 7,853,431 | |
| 01/08/2025 | 10.90 | 11.00 | 10.56 | 10.69 | 2,300,611 | |
| 01/07/2025 | 10.68 | 10.90 | 10.55 | 10.86 | 1,393,072 | |
| 01/06/2025 | 11.09 | 11.19 | 10.68 | 10.69 | 982,678 | |
| 01/03/2025 | 11.07 | 11.52 | 11.04 | 11.06 | 1,364,071 | |
| 01/02/2025 | 10.54 | 11.06 | 10.43 | 11.00 | 897,722 | |
| 12/31/2024 | 10.52 | 10.66 | 10.42 | 10.51 | 702,443 | |
| 12/30/2024 | 10.51 | 10.67 | 10.30 | 10.50 | 771,804 | |
| 12/27/2024 | 10.54 | 10.66 | 10.30 | 10.54 | 493,912 | |
| 12/26/2024 | 10.18 | 10.63 | 10.14 | 10.61 | 632,494 | |
| 12/24/2024 | 10.17 | 10.25 | 9.99 | 10.23 | 279,323 | |
| 12/23/2024 | 10.30 | 10.45 | 9.97 | 10.14 | 803,664 | |
| 12/20/2024 | 9.99 | 10.53 | 9.98 | 10.31 | 1,168,928 | |
| 12/19/2024 | 10.38 | 10.50 | 10.03 | 10.11 | 908,155 | |
| 12/18/2024 | 10.70 | 10.80 | 10.26 | 10.33 | 1,150,015 | |
| 12/17/2024 | 10.87 | 10.95 | 10.57 | 10.73 | 867,666 | |
| 12/16/2024 | 10.55 | 11.15 | 10.40 | 10.93 | 1,292,308 | |
| 12/13/2024 | 10.57 | 10.64 | 10.35 | 10.39 | 1,077,173 | |
| 12/12/2024 | 10.59 | 10.87 | 10.45 | 10.61 | 1,036,567 | |
| 12/11/2024 | 10.81 | 10.98 | 10.28 | 10.32 | 1,377,702 | |
| 12/10/2024 | 10.38 | 10.38 | 9.90 | 10.00 | 1,342,890 | |
| 12/09/2024 | 9.82 | 10.17 | 9.75 | 10.15 | 972,095 | |
| 12/06/2024 | 9.93 | 10.24 | 9.82 | 10.00 | 785,320 | |
| 12/05/2024 | 9.94 | 10.14 | 9.80 | 9.95 | 700,949 | |
| 12/04/2024 | 10.02 | 10.20 | 9.79 | 9.96 | 1,376,782 | |
| 12/03/2024 | 11.30 | 11.44 | 9.41 | 9.94 | 4,254,050 | |
| 12/02/2024 | 11.21 | 11.66 | 11.08 | 11.59 | 747,589 | |
| 11/29/2024 | 11.19 | 11.19 | 10.98 | 11.06 | 558,340 | |
| 11/27/2024 | 11.21 | 11.32 | 11.00 | 11.17 | 724,572 | |
| 11/26/2024 | 11.19 | 11.33 | 10.95 | 11.15 | 1,070,870 | |
| 11/25/2024 | 11.70 | 11.82 | 11.20 | 11.22 | 2,056,497 | |
| 11/22/2024 | 11.76 | 12.22 | 11.53 | 11.66 | 1,576,841 | |
| 11/21/2024 | 10.74 | 11.72 | 10.68 | 11.66 | 1,619,633 | |
| 11/20/2024 | 10.71 | 10.87 | 10.43 | 10.75 | 845,511 | |
| 11/19/2024 | 10.65 | 10.91 | 10.41 | 10.72 | 1,184,797 | |
| 11/18/2024 | 10.89 | 11.01 | 10.44 | 10.72 | 1,338,950 |
About Avadel Pharmaceuticals Stock history
Avadel Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avadel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avadel Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avadel Pharmaceuticals stock prices may prove useful in developing a viable investing in Avadel Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 92.2 M | 96.8 M | |
| Net Loss | -123.7 M | -117.5 M |
Avadel Pharmaceuticals Quarterly Net Working Capital |
|
Avadel Pharmaceuticals Stock Technical Analysis
Avadel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Avadel Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avadel Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Avadel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avadel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.78) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.55) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 26.743 | Return On Assets | Return On Equity |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.